Product Description: Atidortoxumab is a human IgG1κ monoclonal antibody that targets Staph aureus alpha toxin[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]J. Peter R. Pelletier, et al. Passive Monoclonal and Polyclonal Antibody Therapies. Immunologic Concepts in Transfusion Medicine. 2020 : 251–348.